Home Details
| Official Symbol of Gene | Il10 |
| Species | Rattus norvegicus |
| Entrez Gene ID | 25325 |
| Official Full Name | interleukin 10 |
| Also known as | If2a; IL10X |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSRNOG00000004647 AllianceGenome:RGD:2886 |
| Map Location | 13q13 |
| Drug | IL-10 therapy |
| Interaction Type | activator |
| Descent | Dark Agouti rats |
| Disease | MOG-EAE |
| Pubmed ID | 18835435 |
| Year | 2009 |
| Title | Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy |
| Result | This therapy is shown here to reverse inflammation induced paralysis, to reduce disease associated reduction in sensitivity to touch, to prevent the onset of allodynia, to reverse disease associated loss of body weight, and to suppress CNS glial activation associated with disease progression in this model. |
| Mechanism/pathway | The mechanisms by which IL-10 reduces glial activation include both transcriptional and translational actions including suppression of pro-inflammatory gene expression, upregulation of inflammatory cytokine decoy receptors, and reduction in the activation of transcription factors responsible for pro inflammatory gene activation. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.